Short bowel syndrome: Complications, treatment, and remaining questions

Fernando Navarro, Wallace A. Gleason, J. Marc Rhoads, Ruben E. Quiros-Tejeira

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This review deals with the complications and treatment of short bowel syndrome (SBS), addressing the psychosocial, medical, and surgical complications in children receiving long-term parenteral nutrition (PN) support, as well as factors that affect the intestinal adaptation process. Whenever possible, as much of the colon as possible is retained in continuity because the colon is an avid absorber of sodium. It is also important for clinicians to be aware of the important absorption mechanisms in the different regions of the bowel. For example, resection of the terminal ileum removes vitamin B12 transporters and active sodium-coupled bile salt transporters. Treatment of patients missing the terminal ileum may require monthly vitamin B12 injections and oral bile salt binders, such as cholestyramine, when the colon is present to reduce the volume of diarrhea. Patients who do not have ileocecal valves (ICVs) are prone to small bowel bacterial overgrowth that requires treatment to facilitate the intestinal adaptation process. We discuss how the PN is decreased as enteral feedings are advanced as well as clinical monitoring and routine laboratory tests. Although much has been learned over the past 20 years about PN, major questions remain, including determining the optimal form of intravenous lipid (omega-3 preparations versus omega-6 lipids versus a combination of both) to prevent liver disease.

Original languageEnglish (US)
Pages (from-to)e339-e350
JournalNeoReviews
Volume10
Issue number7
DOIs
StatePublished - Dec 1 2009

Fingerprint

Short Bowel Syndrome
Parenteral Nutrition
Colon
Vitamin B 12
Bile Acids and Salts
Ileum
Sodium
Ileocecal Valve
Cholestyramine Resin
Lipids
Enteral Nutrition
Liver Diseases
Diarrhea
Therapeutics
Injections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Short bowel syndrome : Complications, treatment, and remaining questions. / Navarro, Fernando; Gleason, Wallace A.; Rhoads, J. Marc; Quiros-Tejeira, Ruben E.

In: NeoReviews, Vol. 10, No. 7, 01.12.2009, p. e339-e350.

Research output: Contribution to journalArticle

Navarro, Fernando ; Gleason, Wallace A. ; Rhoads, J. Marc ; Quiros-Tejeira, Ruben E. / Short bowel syndrome : Complications, treatment, and remaining questions. In: NeoReviews. 2009 ; Vol. 10, No. 7. pp. e339-e350.
@article{e359ed5f401b4c569fc643aba4858b45,
title = "Short bowel syndrome: Complications, treatment, and remaining questions",
abstract = "This review deals with the complications and treatment of short bowel syndrome (SBS), addressing the psychosocial, medical, and surgical complications in children receiving long-term parenteral nutrition (PN) support, as well as factors that affect the intestinal adaptation process. Whenever possible, as much of the colon as possible is retained in continuity because the colon is an avid absorber of sodium. It is also important for clinicians to be aware of the important absorption mechanisms in the different regions of the bowel. For example, resection of the terminal ileum removes vitamin B12 transporters and active sodium-coupled bile salt transporters. Treatment of patients missing the terminal ileum may require monthly vitamin B12 injections and oral bile salt binders, such as cholestyramine, when the colon is present to reduce the volume of diarrhea. Patients who do not have ileocecal valves (ICVs) are prone to small bowel bacterial overgrowth that requires treatment to facilitate the intestinal adaptation process. We discuss how the PN is decreased as enteral feedings are advanced as well as clinical monitoring and routine laboratory tests. Although much has been learned over the past 20 years about PN, major questions remain, including determining the optimal form of intravenous lipid (omega-3 preparations versus omega-6 lipids versus a combination of both) to prevent liver disease.",
author = "Fernando Navarro and Gleason, {Wallace A.} and Rhoads, {J. Marc} and Quiros-Tejeira, {Ruben E.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1542/neo.10-7-e339",
language = "English (US)",
volume = "10",
pages = "e339--e350",
journal = "NeoReviews",
issn = "1526-9906",
publisher = "American Academy of Pediatrics",
number = "7",

}

TY - JOUR

T1 - Short bowel syndrome

T2 - Complications, treatment, and remaining questions

AU - Navarro, Fernando

AU - Gleason, Wallace A.

AU - Rhoads, J. Marc

AU - Quiros-Tejeira, Ruben E.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - This review deals with the complications and treatment of short bowel syndrome (SBS), addressing the psychosocial, medical, and surgical complications in children receiving long-term parenteral nutrition (PN) support, as well as factors that affect the intestinal adaptation process. Whenever possible, as much of the colon as possible is retained in continuity because the colon is an avid absorber of sodium. It is also important for clinicians to be aware of the important absorption mechanisms in the different regions of the bowel. For example, resection of the terminal ileum removes vitamin B12 transporters and active sodium-coupled bile salt transporters. Treatment of patients missing the terminal ileum may require monthly vitamin B12 injections and oral bile salt binders, such as cholestyramine, when the colon is present to reduce the volume of diarrhea. Patients who do not have ileocecal valves (ICVs) are prone to small bowel bacterial overgrowth that requires treatment to facilitate the intestinal adaptation process. We discuss how the PN is decreased as enteral feedings are advanced as well as clinical monitoring and routine laboratory tests. Although much has been learned over the past 20 years about PN, major questions remain, including determining the optimal form of intravenous lipid (omega-3 preparations versus omega-6 lipids versus a combination of both) to prevent liver disease.

AB - This review deals with the complications and treatment of short bowel syndrome (SBS), addressing the psychosocial, medical, and surgical complications in children receiving long-term parenteral nutrition (PN) support, as well as factors that affect the intestinal adaptation process. Whenever possible, as much of the colon as possible is retained in continuity because the colon is an avid absorber of sodium. It is also important for clinicians to be aware of the important absorption mechanisms in the different regions of the bowel. For example, resection of the terminal ileum removes vitamin B12 transporters and active sodium-coupled bile salt transporters. Treatment of patients missing the terminal ileum may require monthly vitamin B12 injections and oral bile salt binders, such as cholestyramine, when the colon is present to reduce the volume of diarrhea. Patients who do not have ileocecal valves (ICVs) are prone to small bowel bacterial overgrowth that requires treatment to facilitate the intestinal adaptation process. We discuss how the PN is decreased as enteral feedings are advanced as well as clinical monitoring and routine laboratory tests. Although much has been learned over the past 20 years about PN, major questions remain, including determining the optimal form of intravenous lipid (omega-3 preparations versus omega-6 lipids versus a combination of both) to prevent liver disease.

UR - http://www.scopus.com/inward/record.url?scp=77149167332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149167332&partnerID=8YFLogxK

U2 - 10.1542/neo.10-7-e339

DO - 10.1542/neo.10-7-e339

M3 - Article

AN - SCOPUS:77149167332

VL - 10

SP - e339-e350

JO - NeoReviews

JF - NeoReviews

SN - 1526-9906

IS - 7

ER -